Solicitation of Nominations for Appointment to the Advisory Council for the Elimination of Tuberculosis, 8260-8261 [2022-03036]
Download as PDF
<![CDATA[
8260
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
appropriateness, accuracy of
information, courtesy, efficiency of
service delivery, and resolution of
issues with service delivery. Responses
will be assessed to plan and inform
efforts to improve or maintain the
quality of service offered to the public.
If this information is not collected, vital
feedback from customers and
stakeholders on CDC’s services will be
unavailable.
CDC will only submit an individual
collection for approval under this
Generic clearance mechanism if it meets
the following conditions:
• The collection is voluntary;
• The collection is low-burden for
respondents (based on considerations of
total burden hours, total number of
respondents, or burden-hours per
respondent) and are low-cost for both
the respondents and the federal
government;
• The collection is non-controversial
and does not raise issues of concern to
other federal agencies;
• The collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future;
• Personally identifiable information
(PII) is collected only to the extent
necessary and is not retained;
• Information gathered is intended to
be used only internally for general
service improvement and program
management purposes and is not
intended for release outside of the
agency (if released, the agency must
indicate the qualitative nature of the
information);
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
and
• Information gathered will yield
qualitative information (the collection
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study).
Feedback collected under this CDC
Generic clearance provides useful
information, but it does not yield data
that can be generalized to the overall
population. This type of Generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other Generic
mechanisms that are designed to yield
quantitative results.
As a general matter, individual
information collections will not result
in any new system of records containing
privacy information and will not ask
questions of a sensitive nature, such as
sexual behavior and attitudes, religious
beliefs, and other matters that are
commonly considered private.
Based on the number of burden hours
used during the previous approval
period and the number of respondents
involved in this and other expiring
collections, CDC requests OMB approval
for an estimated 22,250 annual burden
hours. There are no costs to respondents
other than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Individuals and Households, Businesses and Organizations, State,
Local or Tribal Government.
In-person surveys, Online surveys,
Telephone surveys, In-person observation/testing, Interviews.
Focus groups ...................................
Customer comment cards, Interactive Voice surveys.
...........................................................
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–03079 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
jspears on DSK121TN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
ACTION:
Notice.
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
Number of
responses per
respondent
Average hours
per response
Total response
burden
(hours)
10,000
1
30/60
5,000
1,000
61,000
1
1
2
15/60
2,000
15,250
........................
........................
........................
22,250
Number of
respondents
Type of respondent
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
Advisory Council for the Elimination of
Tuberculosis (ACET). The ACET
consists of 10 experts including the
Chair in fields associated with public
health, epidemiology, immunology,
infectious disease, pulmonary disease,
pediatrics, tuberculosis, microbiology,
and preventive health care delivery.
ACET provides advice and
recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary, HHS; the Assistant Secretary
for Health, HHS; and the CDC Director.
ACET (a) makes recommendations on
policies, strategies, objectives, and
priorities; (b) addresses development
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
and application of new technologies; (c)
provides guidance and review of CDC’s
TB prevention research portfolio and
program priorities; and (d) reviews the
extent to which progress has been made
toward eliminating TB.
DATES: Nominations for membership on
the ACET must be received no later than
May 31, 2022. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
mailed to CDC, 1600 Clifton Road NE,
Mailstop US8–6, Atlanta, Georgia
30329–4027; or emailed (recommended)
to nchhstppolicy@cdc.gov; or faxed to
(404) 639–8600.
FOR FURTHER INFORMATION CONTACT:
Marah Condit, MS, Committee
E:\FR\FM\14FEN1.SGM
14FEN1
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
Management Lead, National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention, CDC, 1600 Clifton Road NE,
Mailstop US8–6, Atlanta, Georgia
30329–4027, Telephone: (404) 639–
3423; Email: MCondit@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
persons who have expertise and
qualifications necessary to contribute to
the accomplishments of the council’s
objectives. Nominees will be selected on
the basis of their expertise in public
health, epidemiology, immunology,
infectious diseases, pulmonary disease,
pediatrics, tuberculosis, microbiology,
or preventive health care delivery.
Federal employees will not be
considered for membership. Members
may be invited to serve for up to fouryear terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET
objectives.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACET membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2023, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE nominees must be
U.S. citizens and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items to be considered:
D Current curriculum vitae, including
complete contact information
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
(telephone numbers, mailing address,
and email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services. Candidates
may submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (i.e., CDC,
NIH, FDA, etc.).
Nominations may be submitted by the
candidate himself or herself or by a
person or organization recommending
the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–03036 Filed 2–11–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1132; Docket No. CDC–2022–
0023]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Performance Progress and
Monitoring Report (PPMR). The PPMR
is designed to allow CDC to collect
information related to CDC Awardee’s
budgets, strategies and activities, and
the process and outcome performance
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
8261
measures outlined by the cooperative
agreement programs, in order to
evaluate partnerships and the work that
is done on behalf of CDC.
DATES: CDC must receive written
comments on or before April 15, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0023 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Pages 8260-8261]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Council for the Elimination of Tuberculosis
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the Advisory Council for the
Elimination of Tuberculosis (ACET). The ACET consists of 10 experts
including the Chair in fields associated with public health,
epidemiology, immunology, infectious disease, pulmonary disease,
pediatrics, tuberculosis, microbiology, and preventive health care
delivery. ACET provides advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary, HHS; the Assistant
Secretary for Health, HHS; and the CDC Director. ACET (a) makes
recommendations on policies, strategies, objectives, and priorities;
(b) addresses development and application of new technologies; (c)
provides guidance and review of CDC's TB prevention research portfolio
and program priorities; and (d) reviews the extent to which progress
has been made toward eliminating TB.
DATES: Nominations for membership on the ACET must be received no later
than May 31, 2022. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to CDC, 1600 Clifton Road
NE, Mailstop US8-6, Atlanta, Georgia 30329-4027; or emailed
(recommended) to [email protected]; or faxed to (404) 639-8600.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee
[[Page 8261]]
Management Lead, National Center for HIV, Viral Hepatitis, STD, and TB
Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia
30329-4027, Telephone: (404) 639-3423; Email: [email protected].
SUPPLEMENTARY INFORMATION: Nominations are being sought for persons who
have expertise and qualifications necessary to contribute to the
accomplishments of the council's objectives. Nominees will be selected
on the basis of their expertise in public health, epidemiology,
immunology, infectious diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, or preventive health care delivery. Federal
employees will not be considered for membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of ACET objectives.
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees (SGEs), requiring the filing
of financial disclosure reports at the beginning and annually during
their terms. CDC reviews potential candidates for ACET membership each
year and provides a slate of nominees for consideration to the
Secretary of HHS for final selection. HHS notifies selected candidates
of their appointment near the start of the term in July 2023, or as
soon as the HHS selection process is completed. Note that the need for
different expertise varies from year to year and a candidate who is not
selected in one year may be reconsidered in a subsequent year. SGE
nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Candidates should submit the following items to be
considered:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, and email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (i.e., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate himself or herself or
by a person or organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-03036 Filed 2-11-22; 8:45 am]
BILLING CODE 4163-18-P
